Journal of Physiology & Pathology in Korean Medicine (동의생리병리학회지)

The Physiological Society of Korean Medicine and The Society of Pathology in Korean Medicine (대한동의생리학회·한의병리학회)
권호 표지

The Effect of Jeongshin-tang on Interleukin-1 $\beta$ and $\beta$-Amyloid-Induced Cytokine Production in Human Brain Astrocytes

  • Kim Bo Kyung (Department of Neuropsychiatry, College of Oriental Medicine, Dongeui University) ;
  • Shin Soon Shik (Department of oriental medicine, College of Oriental Medicine, Dongeui University) ;
  • Kang Seon Tae (Daesung oriental medical clinic)
  • Published : 2004.02.01
Download PDF
⟨ Previous Next ⟩

Abstract

Jeongshin-tang (JST) is a Korean herbal prescription, which has been successfully applied for the various neuronal diseases. However, it's effect remains unknown in experimental models. To investigate the biological effect of JST in Alzheimer's disease (AD) in vitro model, we analized the production of interleukin (IL)-6 and IL-8, and expression of cyclooxygenase (COX)-2 in IL-1β plus β-amyloid [25-35] fragment (A)-stimulated human astrocytoma cell line U373MG. JST alone had no effect on the cell viability. The production of IL-6 and IL-8 was significantly inhibited by pretreatment with JST (1mg/㎖) on IL-1β plus A-stimulated U373MG cells. Maximal inhibition rate of IL-6 and IL-8 production by JST was about 41.22% (P<0.01) and 34.45% (P<0.05), respectively. The expression level of COX-2 protein was up-regulated by IL-1β plus A but the increased level of COX-2 was inhibited by pretreatment with JST (1 mg/㎖). These data indicate that JST has a regulatory effect on cytokine production and COX-2 expression, which might explain it's beneficial effect in the treatment of AD.

Keywords

References

  1. Bratisl. Lek. Listy. Ferencik M.;Novak M.;Rovensky J.;Rybar I.
  2. Biochem. J. v.311 Iversen L. L.;Mortishire-Smith R. J.;Pollack S. J.;Shearman M. S. https://doi.org/10.1042/bj3110001
  3. Hum. Pathol. v.26 Mark R, E.;Sheng J. G.;Griffin S. T. https://doi.org/10.1016/0046-8177(95)90001-2
  4. Toxicol. Lett. Aschner M.
  5. Brain Res. Rev. v.30 Raivich G.;Bohatschek M.;Kloss C. U. A.;Werner A.;Jones L. L.;Kreutzberg G. W. https://doi.org/10.1016/S0165-0173(99)00007-7
  6. Cytokine v.9 Forloni G.;Mangiarotti F.;Angeretti N.;Lucca E.;De Simoni M. G. https://doi.org/10.1006/cyto.1997.0232
  7. P. Natl. Acad. Sci. U.S.A. v.92 Gitter B. D.;Cox L. M.;Rydel R. E.;May P. C. https://doi.org/10.1073/pnas.92.23.10738
  8. Glia v.40 Eikelenboom P.;Bate C.;Van Gool W. A.;Hoozemans J. J.;Rozemuller J. M.;Veerhuis R.;Williams A. https://doi.org/10.1002/glia.10146
  9. J. Submicrosc. Cytol. Pathol. v.31 Sutton E. T.;Thomas T.;Bryant M. W.;Landon C. S.;Newton C. A.;Rhodin J. A.
  10. P. Natl. Acad. Sci. U.S.A. v.94 Kaltschmidt B.;UherekM.;Volk B.;Baeuerle P. A.;Kaltschmidt C. https://doi.org/10.1073/pnas.94.6.2642
  11. FEBS Lett. v.285 Bauer J.;Strauss S.;Schreiter-Gasser U.;Ganter U.;Schlegel P.;Witt I. https://doi.org/10.1016/0014-5793(91)80737-N
  12. Mol. Neurobiol. v.15 Gruol D. L.;NelsonT. E. https://doi.org/10.1007/BF02740665
  13. Neurosci. Lett. v.186 Yamada K.;Kono K.;Umegaki H.;Yamada K.;Iguchi A.;Fukatsu T. https://doi.org/10.1016/0304-3940(95)11318-Q
  14. J. Biol. Chem. v.275 Akama K. T.;Van Eldik L. J. https://doi.org/10.1074/jbc.275.11.7918
  15. J. Neuroimmunol. v.60 Hayashi M.; Luo Y.;Laning J.;Strieter R. M.;Dorf M. E. https://doi.org/10.1016/0165-5728(95)00064-9
  16. FASEB J. v.7 Ransohoff R. M.;Hamilton T. A.;Tani M.;Stoler M. H.;Shick H. E.;Major J. A.;Estes M. L.;Thomas D. M.;Tuohy V. K. https://doi.org/10.1096/fasebj.7.6.8472896
  17. Neuroscience v.87 Pasinetti G. M.;Aisen P. S. https://doi.org/10.1016/S0306-4522(98)00218-8
  18. Brain Res. v.830 Yasojima K.;Schwab C.;McGeer E. G.;McGeer P. L. https://doi.org/10.1016/S0006-8993(99)01389-X
  19. Neurobiol. Dis. v.6 Rohrenbeck A. M.;Bette M.;Hooper D. C.;Nyberg F.;Eiden L. E.;Dietzschold B.;Weihe E. https://doi.org/10.1006/nbdi.1998.0225
  20. Endocrinology v.144 Jeong H. J.;Na H. J.;Hong S. H.;Kim H. M. https://doi.org/10.1210/en.2003-0115
  21. Expert Opin. Inv. Drug. v.9 Hull M.;Lieb K.;Fiebich B. L. https://doi.org/10.1517/13543784.9.4.671
  22. J. Neuroimmunol. v.59 Meda L.;Bonaiuto C.;Szendrei G. I.;Ceska M.;Rossi F.;Cassatella M. A. https://doi.org/10.1016/0165-5728(95)00021-S
  23. Exp. Neurol. v.132 Pike C. J.;CummingsB. J.;Cotman C. W. https://doi.org/10.1016/0014-4886(95)90022-5
  24. FEBS Lett. v.285 Bauer J.;Strauss S.;Schreiter-Gasser U.;Ganter U.;Schlegel P.;Witt I. https://doi.org/10.1016/0014-5793(91)80737-N
  25. Acta Neuropathol v.89 Huell M.;Strauss S.;Volk B.;Berger M.;Bauer J. https://doi.org/10.1007/BF00571510
  26. J. Biol. Chem. v.277 Bazan N. G.;Lukiw W. J. https://doi.org/10.1074/jbc.M203201200
  27. International Congress Series v.1252 Nogawa S.;Takao M.;Suzuki S.;Tanaka K.;Koto A.;Fukuuchi Y.;Hayakawa I. https://doi.org/10.1016/S0531-5131(03)00076-1
  28. Prostaglandins v.54 Kaufmann W. E.;Andreasson K. I.;Isakson P. C.;Worley P. F. https://doi.org/10.1016/S0090-6980(97)00128-7
  29. Curr. Med. Chem. v.10 Butterfield D. A. https://doi.org/10.2174/0929867033456422
  30. J. Nat. Prod. v.65 Kim S. R.;Lee K. Y.;Koo K. A.;Sung S. H.;Lee N. G.;Kim J.;Kim Y.C. https://doi.org/10.1021/np0202172
  31. J. Ethnopharmacol. v.73 Koo H.N.;Jeong H. J.;Choi J. Y.;Choi S. D.;Choi T. J.;Cheon Y. S.;Kim K. S.;Kang B. K.;Park S. T.;Chang C. H.;Kim C. H.;Lee Y. M.;Kim H. M.;An N. H.;Kim J. J. https://doi.org/10.1016/S0378-8741(00)00287-7
  32. Carbohydr. Res. v.338 Jin Y;Zhang L;Zhang M;Chen L;Cheung P. C.;Oi V. E.;Lin Y. https://doi.org/10.1016/S0008-6215(03)00198-8
  33. Biol. Pharm. Bull. v.26 Koo B. S.;Park K. S.;Ha J. H.;Park J. H.;Lim J. C.;Lee D. U. https://doi.org/10.1248/bpb.26.978
  34. Chem. Pharm. Bull. v.50 Koo K. A.;Sung S. H.;Kim Y. C. https://doi.org/10.1248/cpb.50.834